Trials / Unknown
UnknownNCT04038125
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME (RMSM ICOD STUDY)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Retina Macula Specialists of Miami, LLC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to test the hypothesis that following the use of intravitreal dexamethasone implant for the treatment of DME, there will be an observable increase in the capillary density plexus as denoted by the quantitative assessment of the superficial capillary plexus on OCTA, as well as a decrease in size of the foveal avascular zone (FAZ).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ozurdex Drug Implant Product | Intravitreal Ozurdex injection |
Timeline
- Start date
- 2019-08-22
- Primary completion
- 2020-08-01
- Completion
- 2021-08-01
- First posted
- 2019-07-30
- Last updated
- 2020-03-18
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04038125. Inclusion in this directory is not an endorsement.